Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 117,243 | 112,964 | 101,937 | 104,446 | 114,712 |
| Cost of Goods | 52,964 | 51,315 | 49,955 | 46,009 | 46,630 |
| Gross Profit | 64,279 | 61,649 | 51,982 | 58,437 | 68,082 |
| Operating Expenses | 117,082 | 110,128 | 111,297 | 131,636 | 118,867 |
| Operating Income | -51,839 | -48,164 | -58,360 | -73,190 | -50,155 |
| Interest Expense | 4,279 | 13,893 | 5,824 | 5,820 | 5,808 |
| Other Income | -10,587 | 637 | 385 | -1,167 | 1,173 |
| Pre-tax Income | -66,705 | -61,420 | -63,799 | -80,177 | -54,790 |
| Income Tax | -1,915 | -2,407 | -3,264 | -4,192 | -1,475 |
| Net Income Continuous | -64,790 | -59,013 | -60,535 | -75,985 | -53,315 |
| Net Income | $-64,790 | $-59,013 | $-60,535 | $-75,985 | $-53,315 |
| EPS Basic Total Ops | -0.97 | -1.49 | -1.84 | -2.62 | -1.86 |
| EPS Basic Continuous Ops | -0.97 | -1.49 | -1.84 | -2.62 | -1.86 |
| EPS Diluted Total Ops | -0.97 | -1.49 | -1.84 | -2.62 | -1.86 |
| EPS Diluted Continuous Ops | -0.97 | -1.49 | -1.84 | -2.62 | -1.86 |
| EPS Diluted Before Non-Recurring Items | -0.53 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-34,171 | $-23,213 | $-39,464 | $-54,974 | $-34,040 |